Corrigendum to "ZEB1 regulates the activation of hepatic stellate cells through Wnt/β-catenin pathway" [Eur. J. Pharmacol. 865 (2019) 172787]

Affiliations

• ¹ Institute for Liver Diseases of Anhui Medical University, School of Pharmacy, Anhui Medical University, Hefei, 230032, China.
• ² Hefei Fourth People's Hospital, Affiliated Psychological Hospital of Anhui Medical University, Anhui Medical University, Hefei, 230000, China; Institute for Liver Diseases of Anhui Medical University, School of Pharmacy, Anhui Medical University, Hefei, 230032, China.
• ³ Institute for Liver Diseases of Anhui Medical University, School of Pharmacy, Anhui Medical University, Hefei, 230032, China; Institute of Clinical Pharmacology, Anhui Medical University, Hefei, 230032, China.
• ⁴ Institute for Liver Diseases of Anhui Medical University, School of Pharmacy, Anhui Medical University, Hefei, 230032, China; Department of Pharmacy, Anhui Provincial Cancer Hospital, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, 230031, China.
• ⁵ Clinical Medical College of Anhui Medical University, Anhui Medical University, Hefei, 230032, China.
• ⁶ National Drug Clinical Trial Institution, The First Affiliated Hospital of Bengbu Medical College, China.
• ⁷ Institute for Liver Diseases of Anhui Medical University, School of Pharmacy, Anhui Medical University, Hefei, 230032, China. Electronic address: [email protected].